Immunomodulatory treatment of interstitial lung disease

Interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) have an array of immunomodulatory treatment options compared with IPF, due to their inflammatory component. However, there is a relative paucity of guidance on the management of this heterogeneous group of diseases. In...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Bosch, Laura, Luppi, Fabrizio, Ferrara, Giovanni, Mura, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364223/
https://www.ncbi.nlm.nih.gov/pubmed/35938712
http://dx.doi.org/10.1177/17534666221117002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364223/
https://www.ncbi.nlm.nih.gov/pubmed/35938712
http://dx.doi.org/10.1177/17534666221117002

Ejemplares similares